Intra-operative administration of taurolidine reduces level of interleukin-1 beta rather than povidone-iodine in patients with colon, gastric, and pancreatic cancer. A clinical prospective randomised multicenter trial.

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2006
This article has no abstract
Epistemonikos ID: 7191a1054c53ac257190e12295be2bad0a79991f
First added on: Jan 17, 2025